Phases of Wound Healing

Chronological Overview of Acute Wound Healing

Cutaneous wound repair is a complex, dynamic physiological cascade that restores tissue integrity following injury. In healthy acute wounds, this process progresses seamlessly through four overlapping phases: Hemostasis, Inflammation, Proliferation, and Maturation/Remodeling.

---

Phase 1: Hemostasis (Immediate to Hours)

The immediate objective following tissue injury is to arrest hemorrhage, preserve intravascular volume, and establish a provisional matrix for incoming repair cells.

Microvascular Response & Platelet Activation

Direct physical injury to cutaneous blood vessels triggers an immediate reflex vasoconstriction of local arterioles lasting 5 to 10 minutes, mediated by sympathetic nerve reflexes and the local release of thromboxane A2 and endothelin.

Disruption of the vascular endothelium exposes subendothelial type IV collagen and basement membrane proteins. Circulating platelets (thrombocytes) adhere to exposed collagen via von Willebrand factor (vWF) and glycoprotein receptors (Ib/IX/V and IIb/IIIa). Adherent platelets undergo dramatic conformational activation and degranulate, releasing their intracellular contents:

• Alpha-Granules: Release critical growth factors including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-Beta (TGF-beta), Epidermal Growth Factor (EGF), and Fibroblast Growth Factor (FGF).
• Dense Granules: Release ADP, ATP, serotonin, and histamine, which promote secondary platelet aggregation and subsequent vasodilation.

Coagulation Cascade & Provisional Matrix

Simultaneously, tissue factor (factor III) exposed at the injury site activates the extrinsic coagulation cascade, generating thrombin. Thrombin cleaves soluble plasma fibrinogen into insoluble fibrin monomers, which polymerize into a dense fibrin network. Transglutaminase (factor XIIIa) cross-links the fibrin strands with plasma fibronectin and vitronectin.

This provisional fibrin-fibronectin matrix serves two critical purposes:

1. Provides immediate mechanical hemostasis to plug damaged blood vessels.
2. Creates a structural scaffold and chemotactic reservoir that guides the influx of inflammatory cells into the wound zone.

---

Phase 2: Inflammatory Phase (Days 1 to 5)

Following initial hemostasis, local blood vessels dilate under the influence of histamine, bradykinin, and prostaglandins, increasing vascular permeability. Plasma exudate enters the interstitial space, producing the classic clinical cardinal signs of inflammation: rubor (redness), calor (heat), tumor (swelling), and dolor (pain).

Injury ──> Platelet Alpha-Granules (PDGF / TGF-β) ──> Neutrophils (Peak Days 1-3: ROS & Phagocytosis)
                                                                 │
                                                                 ▼
                                                  Monocytes / Macrophages (Peak Days 2-5)
                                                                 │
                                         ┌───────────────────────┴───────────────────────┐
                                         ▼                                               ▼
                         M1 Phenotype (Pro-inflammatory)                 M2 Phenotype (Pro-healing)
                         TNF-α, IL-1β, clearance of debris               VEGF, TGF-β, fibroblast activation

Neutrophil (PMN) Recruitment & Debridement

Neutrophils (polymorphonuclear leukocytes, PMNs) are the first leukocytes recruited to the wound site, arriving within 24 hours under the influence of chemotactic signals (IL-8, C5a, leukotriene B4, and PDGF). Neutrophil concentration peaks between days 1 and 3.

Primary functions of neutrophils include:

• Phagocytosis: Engulfing bacteria, foreign debris, and damaged extracellular matrix.
• Bactericidal Burst: Releasing reactive oxygen species (ROS) via NADPH oxidase (hydrogen peroxide, superoxide radicals) and antimicrobial peptides.
• Proteolytic Clearance: Releasing neutrophil elastase and MMP-8 (collagenase-2) to digest devitalized tissue.

Once their phagocytic task is completed, neutrophils undergo programmed cell death (apoptosis) and are cleared by macrophages. In uncomplicated wounds, neutrophil numbers rapidly decline after day 3.

Macrophages: Master Regulators of Healing

Circulating monocytes migrate into the wound bed between 48 and 72 hours post-injury, differentiating into tissue macrophages. Macrophage population peaks between days 2 and 5.

Critical Exam Concept: Macrophages are the single most essential cell type in wound repair. Experimental depletion of neutrophils delays healing slightly, but depletion of macrophages completely halts wound repair and prevents granulation tissue formation.

Macrophages function as master orchestrators through a dynamic phenotypic transition:

1. M1 Macrophage Phenotype (Pro-inflammatory): Early macrophages exhibit the M1 phenotype, producing pro-inflammatory cytokines (TNF-alpha, IL-1beta, IL-6) and proteases to clear apoptotic neutrophils and persistent debris.
2. M2 Macrophage Phenotype (Pro-healing): As inflammation resolves, macrophages switch to the M2 phenotype, secreting anti-inflammatory cytokines (IL-10) and vital growth factors (VEGF, TGF-beta, PDGF, FGF). This trophic signaling recruits fibroblasts, stimulates angiogenesis, and initiates the proliferative phase.

---

Phase 3: Proliferative Phase (Days 4 to 21)

The proliferative phase focuses on filling the tissue deficit, re-establishing vascular supply, and restoring cutaneous cover. It is characterized by four concurrent processes: fibroplasia, angiogenesis, re-epithelialization, and wound contraction.

Fibroplasia & ECM Synthesis

Recruited by PDGF and TGF-beta, dermal fibroblasts proliferate and migrate into the wound bed along the provisional fibrin matrix. Fibroblasts synthesize replacement extracellular matrix components, depositing large quantities of type III collagen, fibronectin, and hyaluronic acid. This pale pink, highly vascular stroma constitutes early granulation tissue.

Angiogenesis (Neovascularization)

To support the high metabolic activity of proliferating cells, new capillary blood vessels must form from pre-existing uninjured venules. Driven by local tissue hypoxia (which stabilizes Hypoxia-Inducible Factor 1-Alpha [HIF-1alpha]) and macrophage-derived Vascular Endothelial Growth Factor (VEGF) and basic Fibroblast Growth Factor (bFGF/FGF-2):

• Endothelial cells degrade baseline basement membranes via MMPs.
• Endothelial tip cells migrate toward the VEGF gradient.
• Endothelial stalk cells proliferate, forming hollow capillary loops that loop together to create a rich vascular network, giving granulation tissue its characteristic beefy red, moist, granular appearance.

Re-Epithelialization

Keratinocytes at the wound margins and surrounding surviving dermal adnexal reservoirs lose contact inhibition and undergo epithelial-mesenchymal transition (EMT). Responsive to Epidermal Growth Factor (EGF) and Keratinocyte Growth Factor (KGF/FGF-7):

• Keratinocytes detach from the basement membrane (cleaving BP180 and integrins).
• Keratinocytes flatten, extend pseudopodia, and migrate across the viable granulation bed (using MMP-1 to tunnel beneath non-viable eschar or moist exudate).
• Migration proceeds inward from wound edges until opposing keratinocyte sheets meet, triggering contact inhibition, halting migration, and initiating stratification into epidermal layers.

Wound Contraction

Beginning around day 6 to 10, a subset of dermal fibroblasts within the granulation tissue differentiates into myofibroblasts under the influence of TGF-beta and mechanical tension. Myofibroblasts express alpha-smooth muscle actin (alpha-SMA) microfilaments that connect to ECM fibronectin via integrin complexes.

Myofibroblasts contract in a coordinated fashion, drawing the wound margins inward and reducing total open wound surface area by up to 0.6 to 0.75 mm per day.

---

Phase 4: Maturation & Remodeling Phase (Day 21 to 2 Years)

The final phase of wound repair begins approximately three weeks post-injury, when collagen synthesis and collagen degradation reach equilibrium, and may continue for up to 2 years.

Matrix Turnover & Structural Realignment

During proliferation, fibroblasts rapidly deposit immature, fine, disorganized type III collagen. During remodeling, matrix metalloproteinases (specifically MMP-1, MMP-8, and MMP-13) systematically degrade type III collagen. Concurrently, fibroblasts synthesize dense, mature type I collagen.

Proliferative Phase (Type III Collagen: Fine, Disorganized, Weak)
                               │
                               ▼ [MMPs Cleave Type III / Fibroblasts Synthesize Type I]
Remodeling Phase (Type I Collagen: Thick, Organized Along Lines of Stress) ──> Tensile Strength Max 80%

Collagen fibers are gradually reorganized into parallel bundles aligned precisely along local mechanical lines of stress. Intermolecular covalent cross-links form between collagen triple helices, dramatically enhancing tissue tensile strength. Over time, cellularity and vascularity decrease, converting beefy red granulation tissue into an acellular, avascular, pale white scar.

Tensile Strength Trajectory

• End of Week 1: Tensile strength is approximately 3% of uninjured skin.
• End of Week 3 (21 Days): Tensile strength reaches approximately 20%.
• 3 Months to 2 Years: Tensile strength plateaus at a maximum of 70% to 80% of original uninjured skin.

Crucial Rule: Remodeled scar tissue never regains more than 80% of the tensile strength of original, uninjured cutaneous tissue. Remodeled skin remains permanently at increased risk for recurrent breakdown under mechanical stress.